The latest Cochrane review concurs with recent myopia studies, identifying atropine as most effective in slowing myopia progression.

Eye drops (atropine, pirenzepine gel and cyclopentolate), multifocal spectacles (either bifocal or progressive addition lenses), combinations of eye drops and multifocal spectacles and ortho-k contact lenses were all rated moderate-certainty evidence, while bifocal soft contact lenses were rated low-certainty evidence.

The review also found low-certainty evidence that children wearing under corrected spectacles may have an increased risk of myopia progression, compared with children who wear fully corrected spectacles.

The Cochrane researchers reviewed 41 studies of treatments to slow myopia progression, across 6772 children.